Clinical Study
One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction
Table 1
Demographic and clinical characteristics. BMI indicates body mass index, CAD coronary artery disease, PCI percutaneous coronary intervention, CK creatinine kinase, and CK-MB creatine kinase-muscle and brain.
|